These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20521640)

  • 1. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny.
    De Vriese J; Steensels M; Palya V; Gardin Y; Dorsey KM; Lambrecht B; Van Borm S; van den Berg T
    Avian Dis; 2010 Mar; 54(1 Suppl):246-52. PubMed ID: 20521640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
    Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
    Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
    Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal immunity against avian influenza H5N1 in chickens: limited protection and interference with vaccine efficacy.
    Maas R; Rosema S; van Zoelen D; Venema S
    Avian Pathol; 2011 Feb; 40(1):87-92. PubMed ID: 21331952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector.
    Murr M; Grund C; Breithaupt A; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2020 Dec; 64(4):427-436. PubMed ID: 33347549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.
    Richard-Mazet A; Goutebroze S; Le Gros FX; Swayne DE; Bublot M
    Vet Res; 2014 Oct; 45(1):107. PubMed ID: 25359591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avian influenza in ovo vaccination with replication defective recombinant adenovirus in chickens: vaccine potency, antibody persistence, and maternal antibody transfer.
    Mesonero A; Suarez DL; van Santen E; Tang DC; Toro H
    Avian Dis; 2011 Jun; 55(2):285-92. PubMed ID: 21793447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection afforded by avian influenza vaccination programmes consisting of a novel RNA particle and an inactivated avian influenza vaccine against a highly pathogenic avian influenza virus challenge in layer chickens up to 18 weeks post-vaccination.
    Ladman BS; Gelb J; Sauble LA; Murphy MV; Spackman E
    Avian Pathol; 2019 Aug; 48(4):371-381. PubMed ID: 30961360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.
    Bertran K; Sá E Silva M; Pantin-Jackwood MJ; Swayne DE
    Vaccine; 2013 Aug; 31(35):3572-6. PubMed ID: 23707445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.
    Soejoedono RD; Murtini S; Palya V; Felföldi B; Mató T; Gardin Y
    Avian Dis; 2012 Dec; 56(4 Suppl):923-7. PubMed ID: 23402113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.
    Hassan MK; Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Samy A; Samir M; Le Brun Y; Jobre Y; Aly MM
    Arch Virol; 2012 May; 157(5):951-9. PubMed ID: 22350650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.